The amount of sufferers who would need to be treated for 6 months to prevent one occurrence of a meeting that was part of the principal gastrointestinal end point was 55, and the true number needed to treat to avoid one occurrence of overt gastrointestinal bleeding was 98. There was also a substantial reduction in the amount of sufferers with investigator-defined gastrointestinal occasions with omeprazole in comparison with placebo . The rate of symptoms of gastroesophageal reflux disease at 180 days was 0.2 percent in the omeprazole group and 1.2 percent in the placebo group . There was one case of gastrointestinal obstruction in each of the two groups, without perforations in either combined group.On July 1st Assuming the transaction is completed as prepared, we expect the mixed benefits of increased adjusted EBITDA and a reduced income tax price will produce income accretion of approximately $0.17 to $0.20 per diluted talk about for the second fifty % of 2014 and $0.40 to $0.46 per diluted talk about for 2015. These accretion expectations usually do not include the influence of any future acquisitions beyond the buy of PiC or any transaction-related expenses. Investor Display On 3 June, 2014, representatives of the Company will be participating in the Jefferies 2014 Global Healthcare Conference.